IBL HealthCare Limited (PSX:IBLHL)
Pakistan
· Delayed Price · Currency is PKR 37.33
-3.13 (-7.74%)
At close: Mar 9, 2026
IBL HealthCare Income Statement
Financials in millions PKR. Fiscal year is July - June.
Millions PKR. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | 2020 - 2016 |
| Revenue | 4,218 | 4,322 | 3,603 | 4,028 | 3,651 | 3,004 | Upgrade
|
| Revenue Growth (YoY) | 13.34% | 19.96% | -10.54% | 10.32% | 21.55% | 12.73% | Upgrade
|
| Cost of Revenue | 2,647 | 2,879 | 2,654 | 2,691 | 2,400 | 1,985 | Upgrade
|
| Gross Profit | 1,571 | 1,444 | 949.32 | 1,336 | 1,251 | 1,019 | Upgrade
|
| Selling, General & Admin | 1,135 | 999.3 | 795.96 | 726.7 | 680.77 | 606.06 | Upgrade
|
| Other Operating Expenses | -17.62 | - | - | - | - | - | Upgrade
|
| Operating Expenses | 1,117 | 999.3 | 795.96 | 726.7 | 680.77 | 612.19 | Upgrade
|
| Operating Income | 453.84 | 444.59 | 153.35 | 609.68 | 570.69 | 406.77 | Upgrade
|
| Interest Expense | -46.25 | -58.29 | -65.43 | -64.14 | -25.7 | -26.34 | Upgrade
|
| Interest & Investment Income | - | - | - | - | - | 10.47 | Upgrade
|
| Currency Exchange Gain (Loss) | -8.56 | -12.51 | 27.18 | -109.57 | -72.83 | 3.87 | Upgrade
|
| Other Non Operating Income (Expenses) | 5.96 | 3.3 | 3.7 | 22.86 | 9.81 | 13.09 | Upgrade
|
| EBT Excluding Unusual Items | 404.99 | 377.09 | 118.8 | 458.82 | 481.97 | 407.87 | Upgrade
|
| Gain (Loss) on Sale of Assets | - | - | - | 0.01 | 1.92 | - | Upgrade
|
| Asset Writedown | - | - | -10.1 | - | -0.62 | - | Upgrade
|
| Pretax Income | 404.99 | 377.09 | 108.7 | 458.83 | 483.27 | 409.15 | Upgrade
|
| Income Tax Expense | 191.05 | 168.72 | 101.15 | 149.87 | 180.41 | 108.66 | Upgrade
|
| Net Income | 213.94 | 208.37 | 7.56 | 308.96 | 302.86 | 300.49 | Upgrade
|
| Net Income to Common | 213.94 | 208.37 | 7.56 | 308.96 | 302.86 | 300.49 | Upgrade
|
| Net Income Growth | - | 2658.05% | -97.56% | 2.02% | 0.79% | 36.57% | Upgrade
|
| Shares Outstanding (Basic) | 99 | 99 | 99 | 99 | 99 | 99 | Upgrade
|
| Shares Outstanding (Diluted) | 99 | 99 | 99 | 99 | 99 | 99 | Upgrade
|
| Shares Change (YoY) | - | - | - | - | 0.00% | -0.00% | Upgrade
|
| EPS (Basic) | 2.17 | 2.11 | 0.08 | 3.14 | 3.07 | 3.05 | Upgrade
|
| EPS (Diluted) | 2.17 | 2.11 | 0.08 | 3.14 | 3.07 | 3.05 | Upgrade
|
| EPS Growth | - | 2658.06% | -97.56% | 2.02% | 0.79% | 36.57% | Upgrade
|
| Free Cash Flow | -22.73 | -278.81 | 566.44 | 24.34 | 55.56 | 65.09 | Upgrade
|
| Free Cash Flow Per Share | -0.23 | -2.83 | 5.75 | 0.25 | 0.56 | 0.66 | Upgrade
|
| Dividend Per Share | - | - | - | - | 0.659 | 0.549 | Upgrade
|
| Dividend Growth | - | - | - | - | 19.98% | -49.99% | Upgrade
|
| Gross Margin | 37.25% | 33.40% | 26.35% | 33.18% | 34.28% | 33.92% | Upgrade
|
| Operating Margin | 10.76% | 10.29% | 4.26% | 15.14% | 15.63% | 13.54% | Upgrade
|
| Profit Margin | 5.07% | 4.82% | 0.21% | 7.67% | 8.29% | 10.00% | Upgrade
|
| Free Cash Flow Margin | -0.54% | -6.45% | 15.72% | 0.60% | 1.52% | 2.17% | Upgrade
|
| EBITDA | 458.78 | 447.81 | 156.44 | 612.95 | 575.98 | 411.77 | Upgrade
|
| EBITDA Margin | 10.88% | 10.36% | 4.34% | 15.22% | 15.78% | 13.71% | Upgrade
|
| D&A For EBITDA | 4.94 | 3.22 | 3.09 | 3.28 | 5.29 | 5 | Upgrade
|
| EBIT | 453.84 | 444.59 | 153.35 | 609.68 | 570.69 | 406.77 | Upgrade
|
| EBIT Margin | 10.76% | 10.29% | 4.26% | 15.14% | 15.63% | 13.54% | Upgrade
|
| Effective Tax Rate | 47.17% | 44.74% | 93.05% | 32.66% | 37.33% | 26.56% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.